[PDF][PDF] PSMA ligands for imaging prostate cancer: alternative labeling by complex formation with Al18F2+
HJ Machulla, E Al-Momani - Journal of Nuclear Medicine, 2017 - Soc Nuclear Med
TO THE EDITOR: In the case of prostate cancer, prostate-specific membrane antigen
(PSMA) has been shown to be a valuable target for application by various ligands in clinical …
(PSMA) has been shown to be a valuable target for application by various ligands in clinical …
[^ sup 177^ Lu] Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer
C Kratochwil, FL Giesel, M Eder… - European journal of …, 2015 - search.proquest.com
The prostate-specific membrane antigen (PSMA) shows intense overexpression in the
majority of prostate cancers (PCa)[1]. A Glu-urea-Lys motif has been found to bind with high …
majority of prostate cancers (PCa)[1]. A Glu-urea-Lys motif has been found to bind with high …
Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [18F]AlF-P16-093
Z Zha, SR Choi, K Ploessl, D Alexoff, R Zhao… - Bioconjugate …, 2021 - ACS Publications
Prostate-specific membrane antigen (PSMA)-targeted radioligands have played an
increasing role in the diagnosis of prostate cancer.[68Ga] Ga-P16-093 is a PSMA-targeting …
increasing role in the diagnosis of prostate cancer.[68Ga] Ga-P16-093 is a PSMA-targeting …
PSMA ligands for PET imaging of prostate cancer
SM Schwarzenboeck, I Rauscher… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Targeting the prostate-specific membrane antigen (PSMA) with 68Ga-labeled and 18F-
labeled PET agents has become increasingly important in recent years. Imaging of …
labeled PET agents has become increasingly important in recent years. Imaging of …
[177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer
C Kratochwil, FL Giesel, M Eder… - European Journal of …, 2015 - Springer
The prostate-specific membrane antigen (PSMA) shows intense overexpression in the
majority of prostate cancers (PCa)[1]. A Glu-urea-Lys motif has been found to bind with high …
majority of prostate cancers (PCa)[1]. A Glu-urea-Lys motif has been found to bind with high …
[HTML][HTML] Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals
S Piron, J Verhoeven, C Vanhove, F De Vos - Nuclear Medicine and …, 2022 - Elsevier
Prostate specific membrane antigen (PSMA) is an attractive target for molecular imaging of
prostate cancer and several other solid tumors because of its overexpression in prostate …
prostate cancer and several other solid tumors because of its overexpression in prostate …
Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first …
SN Reske, G Winter, B Baur, HJ Machulla… - European journal of …, 2013 - Springer
Dear Sir, It was with particular interest that we read the article by Afshar-Oromieh et al.[1].
The authors developed a novel 68Ga-labelled prostate-specific membrane antigen (PSMA) …
The authors developed a novel 68Ga-labelled prostate-specific membrane antigen (PSMA) …
Validation of a [Al18F] PSMA-11 preparation for clinical applications
E Al-Momani, I Israel, S Samnick - Applied Radiation and Isotopes, 2017 - Elsevier
Imaging prostate-specific membrane antigen (PSMA) using positron emission tomography
(PET) has been presented so far as the most sensitive and specific with regard to prostate …
(PET) has been presented so far as the most sensitive and specific with regard to prostate …
A novel 18F-labeled PSMA ligand for PET/CT imaging of prostate cancer patients: First-in-man observational study and clinical experience with 18F-JK-PSMA-7 …
F Dietlein, M Hohberg, C Kobe… - Journal of Nuclear …, 2019 - Soc Nuclear Med
In preclinical trials, the recently developed tracer 18 F-JK-PSMA-7 (2-MeO-18 F-DCFPyL)
has been demonstrated to show favorable properties regarding clinical performance and …
has been demonstrated to show favorable properties regarding clinical performance and …
Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives
P Backhaus, B Noto, N Avramovic, LS Grubert… - European journal of …, 2018 - Springer
Background Prostate-specific membrane antigen (PSMA) is the up-and-coming target for
molecular imaging of prostate cancer. Despite its name, non-prostate-related PSMA …
molecular imaging of prostate cancer. Despite its name, non-prostate-related PSMA …